Novel and emerging therapies for B cell lymphoma
Abstract Lymphomas are a heterogeneous group of lymphoproliferative disorders, with unique clinical and biological characteristics that exhibit variable response to therapy. Advances in chemo-immunotherapy have improved outcomes in a number of lymphoma subtypes; however, the prognosis for many patie...
| Hlavní autoři: | , |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
BMC
2019-07-01
|
| Edice: | Journal of Hematology & Oncology |
| Témata: | |
| On-line přístup: | http://link.springer.com/article/10.1186/s13045-019-0752-3 |